The Healthcare Channel

The FDA’s new Breakthrough status for new drug applications

Posted on May 8, 2014 by admin

May 24, 2013- Interviewed by Steven E. Greer, MD

Janet Woodcock, MD,

Posted in - Pharma, FDA | Leave a comment

Drug-coated balloons to treat fem-pop disease

Posted on April 27, 2014 by admin

April 27, 2014– Interviewed by Steven E. Greer, MD

At the Charing Cross symposium in London, Medtronic reported results of the IN-PACT trial Continue reading →

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

Posted on April 24, 2014 by admin

April 24, 2013 By Steven E. Greer, MD

In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal Continue reading →

Posted in FDA | Leave a comment

How many stent cases does it take to bill Medicare for $18 Million?

Posted on April 9, 2014 by admin

April 9, 2014- By Steven E. Greer, MD

The release of data by Medicare showing what each doctor earns from billing CMS is making news for Continue reading →

Posted in Cardiac surgery, Cardiology, CMS, Congress | Leave a comment

The subcutaneous ICD

Posted on March 17, 2014 by admin

The concept of applying high voltage to shock a heart out of Continue reading →

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

Medical Tip: How to get special glasses for computer screen distances, for cheap

Posted on March 14, 2014 by admin

March 14, 2014- By Steven E. Greer, MD

With remarkable regularity across all populations, the inner lens of the eye loses flexibility Continue reading →

Posted in Ohio State, Ophthalmology | Leave a comment

The ACC seems to support dangerous energy drinks

Posted on March 6, 2014 by admin

March 6, 2014- By Steven E. Greer, MD

The Maryland State Assembly will begin debate on a bill to regulate “energy drinks”, such as those Continue reading →

Posted in - Policy, Cardiology | Leave a comment

Book Review: Dragnet Nation by Julia Angwin

Posted on March 2, 2014 by admin

March 2, 2014- By Steven E. Greer, MD

Author of Dragnet Nation, Julia Angwin, won her Pulitzer Prize while working for the Wall Street Continue reading →

Posted in - Reviews, books, devices | Leave a comment

The serious adverse events caused by topical testoserone

Posted on March 1, 2014 by admin

March 1, 2014 Continue reading →

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

FDA investigated by congress for spying on whistleblowers

Posted on February 26, 2014 by admin

Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also Continue reading →

Posted in Congress, FDA | Leave a comment

Tenets of the Palo Alto business model

Posted on February 24, 2014 by admin

February 24, 2014- By Steven E. Greer, MD

With so many young kids becoming billionaires overnight in Silicon Valley, you might be thinking Continue reading →

Posted in - Opinion | Leave a comment

The FDA discusses Brilinta

Posted on February 4, 2014 by admin

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal Continue reading →

Posted in - Pharma, Cardiology, FDA | Leave a comment

Why the lack of outrage over smoking depicted in film and television?

Posted on January 20, 2014 by admin

January 20, 2014

To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey Continue reading →

Posted in - Opinion, Congress, FDA | Leave a comment

Alex Rodriguez’s PED schedule

Posted on January 12, 2014 by admin

January 12, 2014- By Steven E. Greer, MD

CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor Continue reading →

Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology | Leave a comment

Twitter interview with banned-for-life Wall Street tech analyst Henry Blodget

Posted on January 11, 2014 by admin

January 11, 2014- By Steven E. Greer, MD

Disgraced Wall Street sell-side technology sector analyst, Henry Blodget, who was banned for life by Continue reading →

Posted in - Opinion, Congress | Leave a comment

Harvard professors feel the impact in their pocketbooks of the ACA law that they helped pass

Posted on January 5, 2014 by admin

Update January 5, 2014- This is now being reported in the New York Times, two-months after our reporting. Continue reading →

Posted in - Opinion, CMS, Harvard | Leave a comment

The biggest healthcare stories of 2013

Posted on December 23, 2013 by admin

December 23, 2013- By Steven E. Greer, MD

Like a broken record, 2013 was yet another tough year for healthcare companies. Several forces are Continue reading →

Posted in - Opinion, - The Weekly Summary | Leave a comment

Laws governing genetic tests

Posted on December 19, 2013 by admin

December 19, 2013– Interviewed by Steven E. Greer, MD

In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses Continue reading →

Posted in Columbia, Congress, FDA, Genetics | Leave a comment

CBS allows TV doctor to make egregious claims about statins

Posted on November 29, 2013 by admin

Can a “calculator” really tell doctors who should be on Lipitor?

Nortin Hadler, MD: lack of evidence for widespread statin use

The risk of diabetes associated with statin drugs

“You’re telling me this now?” Why the news is suddenly critical of statins and antidepressants

Sanjay Kaul, MD: The Crestor JUPITER indication label expansion

Posted in - Pharma, Cardiology, Cedars Sinai | Leave a comment

The finances of TAVI: do prices have to come down?

Posted on November 8, 2013 by admin

November 8, 2013- Interviewed by Steven E. Greer, MD

William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses the overall market size for TAVI.

Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS | Leave a comment